FGFR inhibitors (Janssen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFGFR inhibitors (Janssen)
Drug Alias NameFGFR inhibitors (J&J)JNJ-42541707JNJ-42441707
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptors antagonistsAnticancer protein kinase inhibitors
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A